BRADLEY, Ill. -- Australian biopharmaceutical company CSL announced Monday a major expansion at its Kankakee manufacturing facility, a move that will bring end-to-end plasma processing into the U.S.

The Kanakee project builds on the company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies. CSL said the ...

SYDNEY--Australia-based pharmaceutical company CSL will expand its Illinois manufacturing facility under a previously announced $1.5 billion move to increase U.S. production. CSL, which produces ...

CSL Behring announced a $1.5 billion expansion to its Bourbonnais Township plant, which would add about 300-400 jobs. The company plans to break ground this summer and have the expansion fully ...

Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee. CSL will expand its current footprint ...

New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 Expansion will create at least 300 new jobs and enhance production of plasma-derived therapies ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Carlisle Companies is a compelling Buy at $374, with a target price of $428 and 14% upside, driven by anticipated Fed rate cuts and construction recovery. CSL's Q4 and 2025 results exceeded revenue ...

The CSL Ltd (ASX: CSL) share price has fallen to its lowest level in almost a decade. On Monday, shares in the biotech giant dropped to $140.93, marking the lowest level since December 2017. At the ...

Abstract: Phase–time arrays, which integrate phase shifters (PSs) and true-time delays (TTDs), have emerged as a cost-effective architecture for generating frequency-dependent rainbow beams in ...

C SL has broken ground for an expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois. The newly expanded facility will substantially increase the global biopharma company’s ...